Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer Journal Article


Authors: Shah, N.; Wang, P.; Wongvipat, J.; Karthaus, W. R.; Abida, W.; Armenia, J.; Rockowitz, S.; Drier, Y.; Bernstein, B. E.; Long, H. W.; Freedman, M. L.; Arora, V. K.; Zheng, D.; Sawyers, C. L.
Article Title: Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer
Abstract: In prostate cancer, resistance to the antiandrogen enzalutamide (Enz) can occur through bypass of androgen receptor (AR) blockade by the glucocorticoid receptor (GR). In contrast to fixed genomic alterations, here we show that GR-mediated antiandrogen resistance is adaptive and reversible due to regulation of GR expression by a tissue-specific enhancer. GR expression is silenced in prostate cancer by a combination of AR binding and EZH2-mediated repression at the GR locus, but is restored in advanced prostate cancers upon reversion of both repressive signals. Remarkably, BET bromodomain inhibition resensitizes drug-resistant tumors to Enz by selectively impairing the GR signaling axis via this enhancer. In addition to revealing an underlying molecular mechanism of GR-driven drug resistance, these data suggest that inhibitors of broadly active chromatin-readers could have utility in nuanced clinical contexts of acquired drug resistance with a more favorable therapeutic index. © Shah et al.
Keywords: immunohistochemistry; controlled study; human cell; sequence analysis; flow cytometry; genetic analysis; reverse transcription polymerase chain reaction; gene expression; gene locus; genetic transcription; cancer resistance; prostate cancer; xenograft; chromatin immunoprecipitation; upregulation; gene silencing; testosterone; transcriptome; glucocorticoid receptor; genetic regulation; histone modification; enzalutamide; antiandrogen therapy; human; article; bromodomain inhibitor
Journal Title: eLife
Volume: 6
ISSN: 2050-084X
Publisher: eLife Sciences Publications Ltd.  
Date Published: 2017-09-11
Start Page: e27861
Language: English
DOI: 10.7554/eLife.27861
PROVIDER: scopus
PMCID: PMC5593504
PUBMED: 28891793
DOI/URL:
Notes: Article -- Export Date: 2 October 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Charles L Sawyers
    225 Sawyers
  2. Wassim Abida
    154 Abida
  3. Neel Shah
    7 Shah
  4. Joshua   Armenia
    56 Armenia